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Abstract Aging is characterized by a progressive dete-
rioration in physiological functions and metabolic pro-
cesses. The loss of cells during aging in vital tissues and
organs is related to several factors including oxidative
stress and inflammation. Skeletal muscle degeneration
is common in elderly people; in fact, this tissue is
particularly vulnerable to oxidative stress since it re-
quires large amounts of oxygen, and thus, oxidative
damage is abundant and accumulates with increasing
age. Melatonin (N-acetyl-5-methoxytryptamine) is a
highly efficient scavenger of reactive oxygen species
and it also exhibits beneficial anti-inflammatory and
anti-aging effects. This study investigated the suscepti-
bility of rat L6 skeletal muscle cells to an induced
oxidative stress following their exposure to hydrogen
peroxide (50 μM) and evaluating the potential
protective effects of pre-treatment with melatonin
(10 nM) compared to the known beneficial effect of
alpha-lipoic acid (300 μM). Hydrogen peroxide-
induced obvious oxidative stress; it increased the ex-
pression of tumour necrosis factor-alpha and in turn
promoted nuclear factor kappa-B and overrode the en-
dogenous defence mechanisms. Conversely, pre-
treatment of the hydrogen peroxide-exposed cells to
melatonin or alpha-lipoic acid increased endogenous
antioxidant enzymes, including superoxide dismutase-
2 and heme oxygenase-1; moreover, they ameliorated
significantly oxidative stress damage and partially re-
duced alterations in the muscle cells, which are typical
of aging. In conclusion, melatonin was equally effective
as alpha-lipoic acid; it exhibited marked antioxidant and
anti-aging effects at the level of skeletal muscle in vitro
even when it was given in a much lower dose than
alpha-lipoic acid.
Keywords Melatonin .α-Lipoic acid . Hydrogen
peroxide . Oxidative stress . Skeletal muscle cell
Introduction
Since individuals in Western societies are living longer,
there is an increasing necessity to understand the path-
ophysiological processes of aging. Aging is associated
with the progressive accumulation of oxidative debris,
which contributes to functional inefficiency of cells,
thereby inducing additional free radical production and
metabolic inefficiency. Thus, aging becomes a vicious
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cycle in which molecular processes fail resulting in
accumulated oxidative damage causing physiological
degeneration; this further exaggerates the production
of free radicals (Cencioni et al. 2013).
A decline in skeletal muscle mass and function is a
consequence of aging as well as of pathological pro-
cesses including cancer, myopathies, and sepsis
(Garatachea and Lucía 2013; Park et al. 2013). Muscle
degeneration is characterized by the deregulation of
calcium homeostasis, enhanced protease activity, loss
of cytoskeletal and sarcolemmal integrity, impaired en-
ergy metabolism and oxidative stress, all of which con-
tribute to muscle atrophy and degeneration (Hopf et al.
2007; Park et al. 2013).
Oxidative stress is a situation related to a serious
imbalance between the production of oxidants, such as
hydrogen peroxide (H2O2) and superoxide anion (O2
·−),
and antioxidant defence mechanisms culminating in
cellular apoptosis or necrosis. The loss of cells due to
programmed cell death is a consequence of/or contrib-
utes to many diseases as well as age-related deteriora-
tion (Halliwell 2003; Reiter 1995; Vinayaga et al. 2006).
Skeletal muscle is particularly vulnerable to oxidative
stress because it requires a large quantity of oxygen, and
thus, muscle cells accumulate significant amounts of
oxidative damage over time. Reactive oxygen species
(ROS) damage many cellular components including
DNA, lipid membranes and proteins (Aoi et al. 2004;
Kozlovsky et al. 1997). Fortunately, cells also possess a
variety of antioxidant defence systems. These include
small molecules such as α-tocopherol and ascorbic acid
that intervene as sacrificial molecules in redox cycles
(Harris 1992). Antioxidants also include specific induc-
ible antioxidant enzymes such as superoxide dismutase
(SOD), catalase, heme oxygenase (HO) and glutathione
peroxidase which either convert oxygen radicals into
less offensive products or prevent their formation
(Devasagayam et al. 2004; Kozlovsky et al. 1997). As
signalling molecules, ROS can activate numerous cel-
lular stress-sensitive pathways, such as the phosphory-
lation of c-Jun N-terminal kinase (JNK) and nuclear
factor kappa-B (NF-kB) (Min et al. 2009), which cause
cell damage. Also, protein kinase signalling pathways
are activated (Sebastián et al. 2012). Tumour necrosis
factor-α (TNF-α), a cytokine produced by monocytes
and macrophages (Kozlovsky et al. 1997; Sprague and
Khalil 2009), is a rapid and potent activator of NF-kB
(Li 2003; Park et al. 2013; Sen et al. 1997). NF-kB, as a
transcription factor, stimulates the expression of a
number of genes related to oxidative stress, immune
responses, inflammation and apoptosis. It is regulated
in a complex manner by the ubiquitin-proteasome sys-
tem; degradation of the NF-kB inhibitor, IkK, by the
proteasome results in activation of NF-kB (Perkins
2007; Skaug et al. 2009; Vriend and Reiter 2014).
Melatonin is a small, highly conserved pineal secre-
tory product with numerous receptor-mediated and
receptor-independent actions (Reiter et al. 2007).
Melatonin is perhaps best known for its mediation of
circannual regulation of metabolism and reproductive
competence in photosensitive species and its ability to
influence circadian processes that are ubiquitous in or-
ganisms and in cells (Campos Costa et al. 2013).
However, it is also well known for its ability to neutral-
ize free radicals, reduce inflammation and defer age-
related dysfunction of several organs (Favero et al.
2014; Galano et al. 2015; Hardeland 2013; Reiter et al.
2014).
Alpha-lipoic acid (1,2-dithiolane-3-pentanoic acid—
LA) is a powerful antioxidant which might act by three
distinct actions: (i) reactive oxygen species-scavenging
activity; (ii) capacity to regenerate endogenous antioxi-
dants, such as glutathione and vitamins C and E and (iii)
metal-chelating activity (Arroll et al. 2014; Packer et al.
1995).
There are rather few studies that have compared the
potential beneficial actions of melatonin with those of
alpha-lipoic acid against induced atrophy and oxidative
stress in a well-characterized in vitro model of skeletal
muscle, rat L6 skeletal muscle cells (Dott et al. 2014;
Jaiswal et al., 2015; Rachek et al. 2007). Herein, we first
analysed the effects of oxidative stress induced by H2O2
on L6 myotubes; thereafter, we evaluated the protective
effects of pre-treatment with melatonin and compared its
antioxidant activity with the known beneficial effects of
LA on L6 cells (Maddux et al. 2001).
Material and methods
L6 rat skeletal myoblasts, obtained from the
Experimental Zooprophylactic Institute of Lombardy
and Emilia Romagna BBruno Ubertini^, were cultured
in Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 10 % heat-inactivated foetal bovine
serum (FBS), penicillin (100 U/ml) and streptomycin
(100 μg/ml) and incubated at 37 °C in a humidified
atmosphere with 5 % carbon dioxide and 95 % air
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atmosphere. The cells, grown in monolayer, were
allowed to differentiate and propagate, and the growth
mediumwas replaced with differentiation medium com-
posed of DMEM supplemented with 2 % FBS, penicil-
lin (100 U/ml) and streptomycin (100 μg/ml), as previ-
ously described by Park et al. (2013) and Vinayaga
Moorthi et al. (2006). Reduction of serum allowed
cell-to-cell fusion and formation of myotubes. In partic-
ular, the differentiation in myotubes was allowed to
progress in 10–14 days and the medium was changed
every 48 h before experimentation. Myogenic differen-
tiation in myotubes was confirmed by morphological
analyses using light microscopy, observing closely the
alignment, elongation and the fusion of cells.
The L6 myoblasts were plated in culture six wells,
induced to differentiate and randomly divided into the
following experimental groups: control, control plus
melatonin, control plus LA, hydrogen peroxide (H2O2)
treatment, melatonin pre-treatment and then H2O2 incu-
bation, and LA pre-treatment and then H2O2 incubation.
The cells of each experimental group were treated at
confluence; L6 myotubes reached confluence in about
1 week.
The cells treated with melatonin were incubated for
24 h in a differentiation medium supplemented with
powder of pure melatonin (Melapure™ by Flamma
S.p.A., Chignolo d’Isola, Italy) at a final concentration
of 10 nM, the maximal effective concentration as deter-
mined in a previous study of Park et al. (2013), in which
melatonin, in a dose-dependent manner, significantly
restored cell survival and attenuated oxidative stress
generation and muscle cell proteolysis. Whereas, the
myotubes, treated with LA for 24 h, were added to
powder of pure LA (Labochim S.p.A., Milan, Italy) at
the final concentration of 300 μM, the maximal effec-
tive dose as determined by Maddux et al. (2001), which
showed that LA protect L6 muscle cells from oxidative
stress-induced insulin resistance in vitro. Melatonin and
LA were directly added to the six-well culture plates,
without changing the differentiation medium or wash-
ing, to avoid ROS production.
In other experimental groups, the myotubes were
treated with H2O2 at the concentration of 50 μM for
1 h, as previously described by Blair et al. (1999). H2O2
is a toxic species that is widely used in cell studies to
induce oxidative stress. It is often used as an exogenous
oxidant treatment to promote free radical generation and
proteolytic signalling pathways in both isolated skeletal
muscles and in in vitro myotubes (Li et al. 2003;
McClung et al. 2009). However, the concentration of
H2O2 used in experiments differs widely in different cell
types. In experiments conducted using myoblasts, a low
concentration (1–10μM) of H2O2 was found to enhance
growth, while moderate and high concentrations (50–
300 μM) were detrimental to the cells (Caporossi et al.
2003; Orzechowski et al. 2002; Shao et al. 2012).
Cell viability assay
At the end of treatment, the myotubes were collected
and resuspended in phosphate buffer solution (PBS), to
which was added 0.4 % trypan blue. Counts of viable
(unstained) and non-viable (blue-stained) cells were
made using a light microscope with a haemocytometer,
and the percentage of viable cells was calculated, as
previously reported by Rezzani et al. (2014). The as-
sessment of cell viability was carried out by two inde-
pendent observers blinded to cell treatments. In case of
dispute concerning interpretation, the case was
reconsidered until agreement was reached.
Measurement of myotube diameter
At the end of treatment, five images were collected per
experimental well, and from each image, the 10 largest
myotubes were measured using an image analyser
(Image Pro Plus; Milan, Italy). In particular, the
myotube diameter, expressed in micrometer, was calcu-
lated by two independent observers blinded to the ex-
perimental group analysed. The myotube diameter was
calculated from the average of three independent mea-
surements per myotube.
Immunofluorescence and morphometrical assay
At the end of the treatments, L6 cells of each experi-
mental group were fixed in 4 % buffered paraformalde-
hyde for 10 min, washed in PBS and incubated in 0.3 %
bovine serum albumin for 1 h at room temperature and
then overnight at 4 °C with the following antibodies:
TNF-α (dilution 1:300; Santa Cruz Biotechnology Inc.,
Dallas, TX, USA), NF-kB (dilution 1:300; Abcam,
Cambridge, UK), superoxide dismutase 2 (SOD2) (di-
lution 1:300; Abcam, Cambridge, UK) and heme
oxygenase-1 (HO-1) (dilution 1:300; Abcam,
Cambridge, UK). Thereafter, the myotubes were la-
belled with the respective conjugated secondary anti-
body (anti-goat or anti-mouse Alexa Fluor 546 or anti-
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rabbit Alexa Fluor 488—diluted 1:200; Life
Technologies, Grand Island, NY, USA). Finally, the
cells were counterstained with 4′,6-diamidino-2-
phenylindole (DAPI), mounted and observed with a
confocal microscope (510 Meta Zeiss, Oberkochen,
Germany), as previously described by Rodella et al.
(2013). The control for the immunofluorescence was
performed by omitting the primary antibody and in the
presence of isotype-matched total immunoglobulin G.
Immunopositivity (staining intensity) of immunoflu-
orescence analyses was computed by two independent
observers blinded to the cell treatments using an optical
fluorescent microscope equipped with an image
analyser (Image Pro Plus; Milan, Italy). The
immunopositivity was calculated by measuring, for
each experimental group, 50 random fields with the
same area (0.04 mm2), as previously described by
Rezzani et al. (2014). The levels of immunopositivity
are expressed as arbitrary units (AU). The data were
pooled to calculate a mean value, and statistical signif-
icance of differences among the experimental groups
was evaluated by ANOVA and Bonferroni test with
significance set at p < 0.05.
Tumour necrosis factor-alpha ELISA procedure
TNF-α concentration in cell lysates was measured using
a commercial in vitro enzyme-linked immunosorbent
assay (ELISA). In particular, we used a specific rat
sandwich ELISA kit (Abcam, Cambridge, UK), accord-
ing to manufacturer’s guidelines. The optical density
was determined at 450 nm in a microplate reader, and
the TNF-α levels were expressed as pg/mL.
Results
Myotube viability and atrophy
The incubation of L6 cells with H2O2 for 1 h reduced
cell survival by 17.8 % (p < 0.05); the dead cells that
underwent apoptosis appeared 5 to 10 μm in size. The
majority of control myotubes, treated or not with mela-
tonin, appeared normal in cells ranging from 10 to
18 μm in size. Interestingly, H2O2-induced inhibition
of cell survival was significantly alleviated bymelatonin
pre-treatment, increasing cell survival by 6.7 %
(p < 0.05) with respect to cells treated only with H2O2.
Moreover, we observed that the treatment of L6
myotubes with LA caused the same trend in terms of
survival as themelatonin-treated group; in particular, the
pre-treatment of L6 cells with LA lowered cell death by
8.8 % (p < 0.05) relative to cell death induced by H2O2
only.
Myotube diameter was analysed as an indicator of
skeletal muscle cell atrophy in response to H2O2 treat-
ment. Myotube diameter decreased by 28.8% (p < 0.05)
in H2O2-incubated cells with respect to those in control
cells, and pre-treatment with melatonin or LA increased
the diameter by 24.4 and 23.2 % (p < 0.05), respectively
(for more details see Fig. 1).
Interestingly, we observed that control cells treated or
not with melatonin or LA for 24 h did not exhibit
significant differences relative to cell vitality or morpho-
logical features; thus, we considered these as a single
group defined generically as Bcontrol^.
Oxidative stress and antioxidant defence
With regard to TNF-α staining (red colour in figures),
H2O2 myotubes showed a strong/very strong
immunopositivity; in contrast, control cells exhibited
absent/very weak immunostaining and the cells pre-
treated with melatonin or LA both exhibited a weak
expression (Fig. 2a–d). In particular, TNF-α staining ex-
hibited a positive and diffuse staining at the cytoplasmic
level with no positivity observed in the nucleus.
Furthermore, these results are confirmed also by the quan-
titative measurement of TNF-α level in cell lysates
(Fig. 2e).
NF-kB immunopositivity (green staining) was higher
in H2O2-incubated cells compared to that in control
myotubes; in particular, H2O2 incubation induced
strong/very strong staining compared to an absent/very
weak signal in control cells (Fig. 2f, g). The pre-
treatment with melatonin or with LA reduced NF-kB
immunopositivity significantly, showing, respectively,
very weak and weak/moderate signals (Fig. 2h, i). Of
interest, NF-kB immunostaining was evident in the
nucleus of cells and no positivity or very weak signal
was observed at the cytoplasmic level. All findings
related to oxidative stress markers were also confirmed
by quantitative analyses, as summarized in Fig. 2l.
The expression of SOD2 (green staining) was lower
in H2O2-treated cells than in control myotubes, in which
it was moderately expressed (Fig. 3a, b). However, both
pre-treatment with melatonin or with LA increased
SOD2 expression (Fig. 3c, d). In particular, H2O2
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incubation induced a very weak expression compared to
the pre-incubation period with melatonin or LA treat-
ments causing, respectively, moderate and weak/
moderate signalling. Specifically, the immunopositivity
was evident in the cytoplasm as Bgranules^, suggesting
mitochondrial SOD2 expression. No positivity was ob-
served in the nucleus.
HO-1 immunostaining, identified in red, was weak in
the L6 myotubes incubated in H2O2 relative to that in the
control cells, in which there was no signal. Interestingly,
pre-treatment with melatonin or LA increased significant-
ly, with moderate/strong signals for HO-1 expression
(Fig. 3e, h). HO-1 immunostaining was evident in the
cytoplasm of the myotubes and there was no positivity
at the nuclear level. These observations were confirmed
by morphometrical analyses, as summarized in Fig. 3i.
Discussion
Herein, we compared the effects of melatonin or LA on
atrophy and oxidative stress of cultured rat L6 myotubes
exposed to H2O2. In accordance with Blair et al. (1999),
H2O2 was shown to be cytotoxic and induced growth
retardation and cell death. H2O2 may also be an impor-
tant molecule that regulates muscle growth; however,
when its concentration is excessive or when the antiox-
idant defence is severely compromised, high levels of
H2O2 cause pathology with consequent cell death via
apoptosis and/or necrosis (Orzechowski et al. 2003). In
our studies, it was shown that H2O2 did not induce
mitogenicity, but it abrogated growth and induced oxi-
dative stress, atrophy and apoptosis. Reduced mitoge-
nicity in rat L6 muscle cells results from the oxidative/
nitrosative stress developed in response to ROS donors
(Orzechowski et al. 2002; 2005).
Previous studies have demonstrated that oxidants and
TNF-α stimulate NF-kB translocation into the nucleus
as well as the expression of genes related to oxidative
stress, cytokines and adhesion molecules in L6 cells
(Aoi et al. 2004; Reid and Li 2001; Vriend and Reiter
2014); this is consistent with the current results. In
particular, the results of the present study indicate that
H2O2-induced oxidative stress was increased and en-
dogenous antioxidant mechanism reduced after TNF-α
stimulation and NF-kB translocation into the nucleus.
Pre-incubation with melatonin or LA limited the atro-
phic and oxidative stress responses, which supports the
Fig. 1 Photomicrographs of L6 myotubes incubated with hydro-
gen peroxide—H2O2 (a), control—CTR (b), pre-treated with mel-
atonin and then incubated in hydrogen peroxide—MEL + H2O2 (c)
or pre-treated with LA and then incubated in hydrogen
peroxide—LA+ H2O2 (d). The myotube viability is expressed as
percentage of viable cells (e) and cell size as myotube diameter in
micrometer (f). *p < 0.05 vs control cells, #p < 0.05 vs hydrogen
peroxide-treated cells and +p < 0.05 vs pre-treated with melatonin
and then incubated in hydrogen peroxide
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antioxidant and anti-aging properties of melatonin
(Favero et al. 2014; Hardeland 2013; Reiter et al.
2014) and confirms the protective effect of LA against
oxidative stress (Maddux et al. 2001).
Oxidative insults to cells are facilitated by the impair-
ment in the function of endogenous antioxidant en-
zymes (Pandey and Rizvi 2011). In fact, the absence
of a compensatory increase in endogenous antioxidant
activity results in the activation of stress-sensitive sig-
nalling pathways (Dhanya et al. 2014). In this context,
the concentration of H2O2 used in the current study was
sufficient to induce cell death, resulting in a weak in-
duction of endogenous antioxidants (SOD and HO-1)
and a significant induction of oxidative stress and
atrophy, as also reported by McClung et al. (2009) in
C2C12 myotubes.
To reduce atrophy and oxidative stress, we pre-
treated the cells with melatonin or LA and observed that
H2O2-induced apoptogenic effects were attenuated.
Melatonin, acting both as a direct and indirect antioxi-
dant, ameliorates mitogenicity also increasing SOD2
and HO-1 expression which, in turn, affected protein
synthesis as did H2O2. Also, LA reduced oxidative
stress and increased endogenous antioxidants, but with
a less obvious protective effect than melatonin.
Fischer et al. (2013) reported a melatonin-mediated
enhancement of the endogenous antioxidative enzyme
activity network as an important and protective mecha-
nism against ultraviolet radiation-induced oxidative
damage to the skin. Interestingly, they observed that
melatonin was not only an effective direct radical scav-
enger but also functioned as an indirect antioxidant
through enhancement of antioxidative enzyme expres-
sion and as a counteracting substance against oxidative
stress-induced DNA damage; these multiple mecha-
nisms of action render melatonin a highly potent anti-
oxidant against oxidative-induced damage.
In this study, we demonstrated that HO-1 activity is
stimulated by both H2O2 and especially by melatonin
pre-treatment in L6 skeletal myotubes and that this
activation is associated with a concomitant important
reduction in oxidative stress. Our results support the
Fig. 2 Immunofluorescence analyses of tumour necrosis factor-
α—TNF-α (a–d) and nuclear factor kappa-B—NF-kB (f–i) in L6
myotubes incubated with hydrogen peroxide—H2O2 (a, f),
control—CTR (b, g), pre-treatedwithmelatonin and then incubated
in hydrogen peroxide—MEL + H2O2 (c, h) and pre-treated with
LA and then incubated in hydrogen peroxide—LA+ H2O2 (d, i).
The insets show the NF-kB-positive nuclei of each experimental
group. Scale bar = 20 μm. The graph (e) represents the quantitative
measure of TNF-α in cell lysates (pg/mL) and summarizes the
quantitative analysis of immunopositivities of both TNF-α and
NF-kB (i). *p < 0.05 vs control cells and #p < 0.05 vs hydrogen
peroxide-treated cells
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finding of Essig et al. (1997) in which it was postulated
that HO-1 is stimulated in rat skeletal muscle and me-
diates cell adaptation to oxidative stress during muscle
contraction. HO-1 is a strong candidate as a key player
in protecting against skeletal muscle damage and has
been reported to perform this action in other cell types as
well (Hirai et al. 2003; Lee et al. 2003; Vesely et al.
1998). The manner by which an increased activity of
HO-1 can be cytoprotective is actually not known. A
major function of HO-1 is to catabolize heme to
Fig. 3 Immunofluorescence analyses for superoxide dismutase
2—SOD2 (a–d) and heme oxygenase-1—HO-1 (e–h) in L6
myotubes incubated with hydrogen peroxide—H2O2 (a, e),
control—CTR (b, f), pre-treated with melatonin and then incubated
in hydrogen peroxide—MEL+H2O2 (c, g) and pre-treated with LA
and then incubated in hydrogen peroxide—LA+ H2O2 (d, h).
Nuclei were stained with DAPI. Scale bar = 20 μm. The graph
(i) summarizes the quantitative analysis of immunopositivities.
*p < 0.05 vs control cells, #p < 0.05 vs H2O2-treated cells and
+p < 0.05 vs pre-treated with melatonin and then incubated in
hydrogen peroxide
Fig. 4 A schematic
representation of hydrogen
peroxide-mediated alterations in
skeletal muscle cell and an
illustration of the protective
antioxidant and anti-aging effects
of melatonin
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generate bilirubin, carbon monoxide and free iron, all of
which may play direct or indirect roles in the
cytoprotective effects of HO-1 (McArdle et al. 2004;
Morse and Choi 2002).
Because induction of ROS production appears to
play a central function in several diseases associated
with aging, antioxidant upregulation represents a fun-
damental mechanism by which melatonin may exert
therapeutic effects against oxidative stress and atro-
phy associated with these conditions. The protective
effects of melatonin and its metabolites are currently
attributed to melatonin’s radical scavenging and an-
tioxidant properties (Galano et al, 2013; Zhang and
Zhang 2014). In this study, both direct and indirect
antioxidant properties of melatonin were observed;
this indoleamine directly scavenges a variety of the
ROS including H2O2 and the highly deleterious hy-
droxyl radical (Reiter et al. 2002; Tengattini et al.
2008). Additionally, melatonin indirectly stimulates
the expression and activity of antioxidant enzymes,
including glutathione peroxidase, SOD, glutathione
reductase and catalase as reported also by Park et al.
(2013) and Rodriguez et al. (2004). In particular,
Park et al. (2013) examined melatonin’s potential to
protect skeletal muscle cells against TNF-α-induced
muscle atrophy in an in vitro model and observed that
it increased cellular antioxidant mechanisms.
Melatonin protects L6 myotubes from damage in-
duced by H2O2 (Fig. 4); this effect might be achieved
by maintaining the integrity of cellular integrity due to a
reduction in oxidative stress and apoptosis and by
increasing antioxidant defence responses thereby
exerting a protective effect similar to that observed by
Maddux et al. (2001) with LA pre-treatment. In the
current study, we evaluated the protective actions of
the pre-treatment with melatonin and compared its anti-
oxidant activity with the known beneficial effects of LA.
This comparison showed that melatonin pre-treatment
was more efficient with respect to LA pre-treatment in
increasing endogenous antioxidant enzymes (SOD2 and
HO-1); this was especially obvious considering the re-
spective concentrations of the molecules used, i.e.,
10 nM for melatonin and 300 μM for LA. Since mela-
tonin has both direct free radical-scavenging actions and
the ability to promote antioxidant enzyme activities, it
seems it may be a highly beneficial molecule to protect
skeletal muscle not only from toxin or drug exposure but
also from the degenerative changes associated with
aging. However, what percentage of its benefits derives
from each of the multiple actions of the indoleamine
remains to be investigated.
In summary, the current findings document that oxi-
dative stress imposed on L6 myotubes causes atrophy
and molecular damage, but also an attempt of a com-
pensatory adaptive response which results in a weak
expression of antioxidants that in turn may activate
cellular defence mechanisms. Since a reduction in oxi-
dative stress is an important target for drug-based ther-
apies and strategies to prevent damage during aging-
related diseases, discovering methods to attenuate it in
all tissues including skeletal muscle could provide a
means for protecting these vital cells from atrophy and
aging-related pathophysiological processes. Further
studies on this topic are mandatory in vitro, using also
other additional skeletal muscle cell type, like C2C12
myotubes. C2C12 cells are grown as proliferative myo-
blasts and, upon reaching confluence, begin to differen-
tiate, fusing into elongated, multinucleated and occa-
sionally contractile fibres (Herbst et al. 2014), as L6
cells used in the present study.Moreover, to better assess
the potential role of melatonin and LA as modulators of
oxidative stress and skeletal muscle damage, other stud-
ies on their effect in combination will be an important
and interesting issue for future study.
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